Alpha Tau Medical Target Price

Analysts' average 12-month price target for Alpha Tau Medical is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.62

Average Target Price

$14.20

2.9% downside

5 analysts in the last 4 months

High: $17 | Low: $8

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-11	H.C. Wainwright	$16	9.4% upside
2026-06-04	Barclays	$17	16.3% upside
2026-05-28	BarclaysLukas Shumway	$15	2.6% upside
2026-05-19	Piper Sandler	$8	45.3% downside
2026-05-12	H.C. Wainwright	$15	2.6% upside
2026-02-24	H.C. WainwrightYi Chen	$12	17.9% downside
2025-09-03	H.C. WainwrightYi Chen	$9	38.4% downside
2024-05-21	Piper SandlerJason Bednar	$7	52.1% downside
2022-11-23	Piper Sandler	$12	17.9% downside

Alpha Tau Medical (DRTS) FAQ

Alpha Tau Medical posts a target price of $14. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $14 for DRTS means covering analysts, on average, see the stock 2.9% downside of $14.62 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for DRTS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Alpha Tau Medical's other metric pages and overview cover the third.